The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review
Open accessAbstract
Objectives: In this systematic review, we aim to identify laboratory biomarkers that predict response to tumour necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA). Methods: EMBASE, PubMed and Cochrane Library (CENTRAL) were searched for studies that presented predictive accuracy measures of laboratory biomarkers, or in which these were calculable. Likelihood ratios were calculated in order to determine whether a test result relevantly changed the probability of response. Likelihood ratios between 2–10 and 0.5–0.1 were considered weak predictors, respectively, and ratios above 10 or below 0.1 were considered strong predictors of response. Primary focus was on biomarkers studied ≥3 times. Results: From 41 included studies, data on 99 different biomarkers were extracted. Five biomarkers were studied ≥3 times, being (1) anti-cyclic citrullinated peptide (CCP), (2) rheumatoid factor, (3) –308 polymorphism in the TNF-α gene, (4) SE copies in the HLA-DRB1 gene and (5) FcGR2A polymorphism. No studies showed a strong predictive association and only one study on anti-CCP showed a weak positive association. Conclusions: No biomarkers were found that consistently showed a (strong) predictive effect for response to TNFi in patients with RA. Given the disappointing yield of previous predictive biomarker research, future studies should focus on exploring, combining and validating the most promising laboratory biomarkers identified in this review, and searching for new predictors. Besides this, they should focus on contexts where prediction-aided decision-making can have a large impact (even with limited predictive value of markers/models). PROSPERO registration number: CRD42021278987.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite several attempts, including machine learning utilisation,42–44 no single established biomarker has been reported in a real-life setting.45”
From Diurnal production of cortisol and prediction of treatment response in rheumatoid arthritis: a 6-month, real-life prospective cohort study (2024) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · BMJ · doi:10.1136/bmj.h5527 · Cited by 3,660 · cited 1×
“38 However, this criterion led to exclusion of many studies (n=80).”
Smolen, J. S., Landewé, R., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A. R., van Vollenhoven, R., de Wit, M. P. T., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,845
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,080
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,171
Chapter 12: Interpreting results and drawing conclusions
Schünemann, H. J., Oxman, A. D., Jonathan, J., & Glasziou, P. (2011) · Cited by 870
Hyrich, K. L., Watson, K. D., Silman, A. J., Symmons, D. P. M., & Register, T. B. B. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel149 · Cited by 623
Bartelds, G. M., Wijbrandts, C. A., Nurmohamed, M. T., Stapel, S. O., Lems, W. F., Aarden, L. A., Dijkmans, B. A. C., Tak, P. P., & Wolbink, G. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065615 · Cited by 561
Mugnier, B., Balandraud, N., Darque, A., Roudier, C., Roudier, J., & Reviron, D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11168 · Cited by 223
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis
Padyukov, L., Lampa, J., Heimbürger, M., Ernestam, S., Cederholm, T., Lundkvist, I., Andersson, P., Hermansson, Y., Harju, A., Klareskog, L., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.526 · Cited by 197
Cited by
Management strategies in rheumatoid arthritis
Konzett, V., & Aletaha, D. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01169-7 · Cited by 108
Ruscitti, P., Allanore, Y., Baldini, C., Barilaro, G., Bocci, E. B., Bearzi, P., Bellis, E., Berardicurti, O., Biaggi, A., Bombardieri, M., et al. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103581 · Cited by 36
Immune-cell profiling to guide stratification and treatment of patients with rheumatic diseases
Rao, D. A. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01291-0 · Cited by 22
Nasonov, E. L., Avdeeva, A. S., & Dibrov, D. A. (2023) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2023-276-291 · Cited by 15
Yavropoulou, M. P., Filippa, M. G., Vlachogiannis, N. I., Fragoulis, G. E., Laskari, K., Mantzou, A., Panopoulos, S., Fanouriakis, A., Bournia, V.-K., Evangelatos, G., et al. (2024) · RMD Open · doi:10.1136/rmdopen-2023-003575 · Cited by 13
“45 Finally, the lack of noteworthy changes of diurnal production of saliva cortisol over time, in spite of the significant treatment-induced changes in disease activity and degree of stress, provides additional evidence that the impaired adrenal reserve in RA is probably an intrinsic condition…”
Background
Metadata
- Authors
- Wientjes, M. H. M., den Broeder, A. A., Welsing, P. M. J., Verhoef, L. M., & van den Bemt, B. J. F.
- Affiliations
- Radboud University Nijmegen (NL)
- University Medical Center Utrecht (NL)
- Sint Maartenskliniek (NL)
- Corresponding author
- Wientjes, Maike H M
- Venue
- RMD Open
- Publisher
- BMJ
- Published
- 2022-12
- Volume
- 8
- Issue
- 2
- Pages
- e002570
- ISSN
- 2056-5933 (ISSN-L)
- PMC
- PMC9730399
- OpenAlex
- W4310747330
- Cited by
- 18
- References
- 38
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 1
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- RMD Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, tumor necrosis factor inhibitors, predictive biomarkers, laboratory biomarkers, anti-CCP antibodies, rheumatoid factor, TNF-α -308 polymorphism, likelihood ratios, treatment response prediction
- MeSH terms
- Tumor Necrosis Factor Inhibitors, Arthritis, Rheumatoid, Autoantibodies, Humans, Rheumatoid Factor, Biomarkers, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review. https://app.cochat.ai/papers/10.1136/rmdopen-2022-002570
- The paper
- Wientjes, M. H. M., den Broeder, A. A., Welsing, P. M. J., Verhoef, L. M., & van den Bemt, B. J. F. (2022). Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review. RMD Open. https://doi.org/10.1136/rmdopen-2022-002570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
